Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infection
Authors:
- A.L.W.F. EddlestonAEA.L.W.F. Eddleston
- G.J.M. AlexanderGAG.J.M. Alexander
- R. WilliamsRWR. Williams
- A. MeagerAMA. Meager
- 1 April 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8694) , 875-877
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tumor Necrosis Factor α Production by Peripheral Blood Mononuclear Cells of Patients With Chronic Liver DiseaseHepatology, 1989
- Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.Gut, 1987
- The Antiviral Activity of Recombinant Human Tumor Necrosis Factor-αJournal of Interferon Research, 1987
- Tumour necrosis factors α and β inhibit virus replication and synergize with interferonsNature, 1986
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.Journal of Experimental Medicine, 1986
- Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infectionJournal of Medical Virology, 1985
- Stimulation of Fibroblast Interferon Production by a 22K Protein from Human LeukocytesJournal of General Virology, 1985
- Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1Nature, 1985